Cargando…
Road Map to Understanding SARS-CoV-2 Clinico-Immunopathology and COVID-19 Disease Severity
SARS-CoV-2, a novel coronavirus, was first identified in Wuhan, China in December 2019. The rapid spread of the virus worldwide prompted the World Health Organization (WHO) to declare COVID-19 a pandemic in March 2020. COVID-19 discontinuing’s a global health crisis. Approximately 80% of the patient...
Autores principales: | Karmakar, Deepmala, Lahiri, Basudev, Ranjan, Piyush, Chatterjee, Jyotirmoy, Lahiri, Pooja, Sengupta, Sanghamitra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823523/ https://www.ncbi.nlm.nih.gov/pubmed/33374748 http://dx.doi.org/10.3390/pathogens10010005 |
Ejemplares similares
-
Comprehensive Evaluation of PAXgene Fixation on Oral Cancer Tissues Using Routine Histology, Immunohistochemistry, and FTIR Microspectroscopy
por: Lahiri, Pooja, et al.
Publicado: (2021) -
IL-6: Relevance for immunopathology of SARS-CoV-2
por: Gubernatorova, E.O., et al.
Publicado: (2020) -
Sarcoidosis and COVID-19: At the Cross-Road between Immunopathology and Clinical Manifestation
por: Tana, Claudio, et al.
Publicado: (2022) -
STING, a critical contributor to SARS-CoV-2 immunopathology
por: Li, Heyu, et al.
Publicado: (2022) -
Tissue immunity to SARS‐CoV‐2: Role in protection and immunopathology
por: Rybkina, Ksenia, et al.
Publicado: (2022)